Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cardiovascular disease and hypertensive disorders of pregnancy (HDP) are the leading causes of maternal morbidity and mortality in the United States. Postpartum, in office care has demonstrated to be an insufficient model of hypertensive management postpartum, largely due to barriers that women face in accessing in office care, with stark racial disparities in access. The care of postpartum patients with HDP following delivery is made up of either a single postpartum visit at 6 weeks postpartum or a fragmented and non-standardized series of in-person appointments depending on the patients' medical complications and the clinicians' experience. Further, current society guidelines outline inpatient thresholds for initiation of antihypertensive medication but do not provide recommendations for titration thereafter. The proposed study will investigate the acceptability and effectiveness of an algorithm-based, outpatient treatment model for the management of postpartum hypertension utilizing an asynchronous text-based platform as compared to the standard of care for postpartum women with a diagnosis of Hypertensive disorder of pregnancy at Massachusetts General Hospital.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental | Experimental |
| |
| Usual Care | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Remote blood pressure monitoring | Behavioral | Participants assigned to this arm will participate in the experimental intervention |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percent of patients who are normotensive at 6 weeks postpartum by American College of Cardiology (ACC)/American Heart Association (AHA) guidelines | Percent of patients who are normotensive at 6 weeks postpartum by ACC/AHA guidelines (>130/80) in each treatment group | 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Percent of patients who are normotensive at 6 weeks postpartum by American College of Obstetricians and Gynecologists (ACOG) guidelines | Percent of patients who are normotensive at 6 weeks postpartum by ACOG guidelines (>140/90) in each treatment group | 6 weeks |
| Frequency of Hospital readmission |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ilona T Goldfarb, MD | Contact | 617-724-2640 | igoldfarb@partners.org |
Not provided
Not provided
Not provided
In this study, we are testing different strategies to help women decrease issues with hypertension in the postpartum period. Participants may or may not undergo some of the following study procedures:
Not provided
Not provided
Not provided
| Usual Care | Behavioral | Participants assigned to this arm will participate in a placebo intervention |
|
Frequency of Hospital readmission in the first 6 weeks postpartum in each treatment group |
| 6 weeks |
| Number of medication titrations | Mean number of medication titrations by patient in the first 6 postpartum weeks in each treatment group | 6 weeks |
| Adherence with scheduled outpatient clinical appointments | Percent of scheduled outpatient clinical appointments attended by patients in the first 6 postpartum months in each treatment group | 6 months |
| Establishment of care with a primary care doctor | Percent of patients who attend a primary care doctor visit in the first postpartum year in each treatment group | 1 year |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011225 | Pre-Eclampsia |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D006973 | Hypertension |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided